{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:56:15Z","timestamp":1777398975480,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.msard.2024.105685","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T06:53:36Z","timestamp":1715669616000},"page":"105685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Neuromyelitis optica spectrum disorders registry system in Iran: Validity of data sets"],"prefix":"10.1016","volume":"87","author":[{"given":"Faezeh","family":"Khodaie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahsa Mohammadi","family":"Lapevandani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasamin","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Ali","family":"Sahraian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdorreza Naser","family":"Moghadasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeideh","family":"Ayoubi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houman","family":"Goudarzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sepideh","family":"Paybast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naser","family":"Kamyari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasrin","family":"Asgari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Fujihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hora","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8942-9983","authenticated-orcid":false,"given":"Sharareh","family":"Eskandarieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Winter","key":"10.1016\/j.msard.2024.105685_bib0001","article-title":"The development of a minimum data set for an infertility registry","volume":"15","author":"Abbasi","year":"2018","journal-title":"Perspect. Health Inf. Manage"},{"issue":"2","key":"10.1016\/j.msard.2024.105685_bib0002","first-page":"214","article-title":"Evaluation of methods used for estimating content validity. Research in social & administrative pharmacy","volume":"15","author":"Almanasreh","year":"2019","journal-title":"RSAP"},{"key":"10.1016\/j.msard.2024.105685_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104610","article-title":"The national multiple sclerosis registry system of Iran (NMSRI): aspects and methodological dimensions","volume":"72","author":"Ayoubi","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105685_bib0004","doi-asserted-by":"crossref","DOI":"10.1007\/s10072-023-06617-y","article-title":"Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis","author":"Bagherieh","year":"2023","journal-title":"Neurol. Sci."},{"issue":"5","key":"10.1016\/j.msard.2024.105685_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232368","article-title":"Operational method of reliability and content-validity analysis: taking \"trait-symptoms\" screening of individuals at high-risk for OCD as an example","volume":"15","author":"Bao","year":"2020","journal-title":"PLoS. One"},{"issue":"6","key":"10.1016\/j.msard.2024.105685_bib0006","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1177\/1352458506070775","article-title":"MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis","volume":"12","author":"Butzkueven","year":"2006","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.msard.2024.105685_bib0007","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12974-021-02249-1","article-title":"Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies","volume":"18","author":"Carnero Contentti","year":"2021","journal-title":"J. Neuroinflammation."},{"issue":"1","key":"10.1016\/j.msard.2024.105685_bib0008","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12974-022-02420-2","article-title":"Treatment regimens for neuromyelitis optica spectrum disorder attacks: a retrospective cohort study","volume":"19","author":"Demuth","year":"2022","journal-title":"J. Neuroinflammation."},{"key":"10.1016\/j.msard.2024.105685_bib0009","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.msard.2017.10.007","article-title":"Neuromyelitis optica spectrum disorders in Iran","volume":"18","author":"Eskandarieh","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.msard.2024.105685_bib0010","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1759-1961.2012.00030.x","article-title":"Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease","volume":"3","author":"Fujihara","year":"2012","journal-title":"Clin. Exper. Neuroimmunol."},{"issue":"9\u201310","key":"10.1016\/j.msard.2024.105685_bib0011","doi-asserted-by":"crossref","first-page":"317","DOI":"10.18071\/isz.72.0317","article-title":"[The Expanded Disability Status Scale scoring in patients with multiple sclerosis]","volume":"72","author":"F\u00fcvesi","year":"2019","journal-title":"Ideggyogy. Sz."},{"key":"10.1016\/j.msard.2024.105685_bib0012","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3389\/fneur.2020.00501","article-title":"Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide","volume":"11","author":"Hor","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2024.105685_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104023","article-title":"The description of neuromyelitis optica spectrum disorder: patient registry in Yangtze River Delta area of China","volume":"66","author":"Huang","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.msard.2024.105685_bib0014","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41572-020-0214-9","article-title":"Neuromyelitis optica","volume":"6","author":"Jarius","year":"2020","journal-title":"Nature Rev. Disease Primers"},{"key":"10.1016\/j.msard.2024.105685_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101868","article-title":"Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorder","volume":"38","author":"Kunchok","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"4","key":"10.1016\/j.msard.2024.105685_bib0016","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1744-6570.1975.tb01393.x","article-title":"A Quantitative approach to content validity1","volume":"28","author":"LAWSHE","year":"1975","journal-title":"Pers. Psychol."},{"issue":"5","key":"10.1016\/j.msard.2024.105685_bib0017","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001057","article-title":"COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America: from the COViMS Registry","volume":"8","author":"Newsome","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2024.105685_bib0018","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3389\/fpubh.2020.00457","article-title":"Delphi Technique in Health Sciences: a Map","volume":"8","author":"Niederberger","year":"2020","journal-title":"Front. Public Health"},{"issue":"5","key":"10.1016\/j.msard.2024.105685_bib0019","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/nur.20147","article-title":"The content validity index: are you sure you know what's being reported? Critique and recommendations","volume":"29","author":"Polit","year":"2006","journal-title":"Res. Nurs. Health"},{"issue":"4","key":"10.1016\/j.msard.2024.105685_bib0020","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/nur.20199","article-title":"Is the CVI an acceptable indicator of content validity? Appraisal and recommendations","volume":"30","author":"Polit","year":"2007","journal-title":"Res. Nurs. Health"},{"issue":"17_supplement_2","key":"10.1016\/j.msard.2024.105685_bib0021","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1212\/WNL.0000000000204303","article-title":"MGBase: the launch of an international electronic database for patients with Myasthenia Gravis (P7-8.014)","volume":"100","author":"Reddel","year":"2023","journal-title":"Neurology."},{"issue":"9","key":"10.1016\/j.msard.2024.105685_bib0022","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1007\/s10072-020-04393-7","article-title":"Epidemiology of neuromyelitis optica spectrum disorder in Tehran, Iran: the prevalence, baseline characteristics, and clinical aspects","volume":"41","author":"Rezaeimanesh","year":"2020","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.msard.2024.105685_bib0023","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1186\/s12891-017-1914-5","article-title":"Development and validation of a new tool to measure the facilitators, barriers and preferences to exercise in people with osteoporosis","volume":"18","author":"Rodrigues","year":"2017","journal-title":"BMC. Musculoskelet. Disord."},{"issue":"6","key":"10.1016\/j.msard.2024.105685_bib0024","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s10072-019-04230-6","article-title":"Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina: comparing baseline data from the Argentinean MS Registry (RelevarEM)","volume":"41","author":"Rojas","year":"2020","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.msard.2024.105685_bib0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.msard.2019.05.004","article-title":"The Argentinean multiple sclerosis registry (RelevarEM): methodological aspects and directions","volume":"32","author":"Rojas","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105685_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103258","article-title":"Neuromyelitis optica spectrum disorders: a nationwide Portuguese clinical epidemiological study","volume":"56","author":"Santos","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105685_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2021.106789","article-title":"Explaining the individual challenges of women affected by neuromyelitis optica and multiple sclerosis: a comparative content analysis Study","volume":"207","author":"Shabany","year":"2021","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.msard.2024.105685_bib0028","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.msard.2019.06.009","article-title":"Multiple sclerosis national registry system in Iran: validity and reliability of a minimum data set","volume":"33","author":"Shahin","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.msard.2024.105685_bib0029","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12874-017-0343-3","article-title":"Clinical patient registry recruitment and retention: a survey of patients in two chronic disease registries","volume":"17","author":"Solomon","year":"2017","journal-title":"BMC. Med. Res. Methodol."},{"issue":"2","key":"10.1016\/j.msard.2024.105685_bib0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2024.105685_bib0031","doi-asserted-by":"crossref","first-page":"165","DOI":"10.15171\/jcs.2015.017","article-title":"Design and implementation content validity study: development of an instrument for measuring patient-centered communication","volume":"4","author":"Zamanzadeh","year":"2015","journal-title":"J. Caring Sci."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824002621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824002621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T12:07:36Z","timestamp":1720872456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034824002621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":31,"alternative-id":["S2211034824002621"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.105685","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuromyelitis optica spectrum disorders registry system in Iran: Validity of data sets","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.105685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105685"}}